Published in Chest on July 01, 2005
Multimodal treatment of esophageal cancer. Langenbecks Arch Surg (2012) 0.88
Prolonged postoperative length of stay is associated with poor overall survival after an esophagectomy for esophageal cancer. J Thorac Dis (2015) 0.87
Emerging aspects of oesophageal and gastro-oesophageal junction cancer histopathology - an update for the surgical oncologist. World J Surg Oncol (2006) 0.86
Chemotherapeutic agents increase the risk for pulmonary function test abnormalities in patients with multiple myeloma. Clin Lymphoma Myeloma Leuk (2012) 0.75
The ameliorative effect of silibinin against radiation-induced lung injury: protection of normal tissue without decreasing therapeutic efficacy in lung cancer. BMC Pulm Med (2015) 0.75
Pulmonary Function Changes After Radiotherapy for Lung or Esophageal Cancer: A Systematic Review Focusing on Dose-Volume Parameters. Oncologist (2017) 0.75
First-line crizotinib versus chemotherapy in ALK-positive lung cancer. N Engl J Med (2014) 10.91
Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 4.83
7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol (2010) 4.52
Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res (2012) 3.33
The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol (2006) 3.25
Detection of lung cancer by sensor array analyses of exhaled breath. Am J Respir Crit Care Med (2005) 2.94
American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol (2006) 2.68
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68
The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg (2008) 2.67
A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands. Am J Hum Genet (2010) 2.59
Electromagnetic navigation diagnostic bronchoscopy: a prospective study. Am J Respir Crit Care Med (2006) 2.40
A novel approach to cancer staging: application to esophageal cancer. Biostatistics (2009) 2.31
Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution. J Clin Oncol (2006) 2.20
Refining esophageal cancer staging. J Thorac Cardiovasc Surg (2003) 2.18
An antiapoptotic BCL-2 family expression index predicts the response of chronic lymphocytic leukemia to ABT-737. Blood (2011) 2.16
Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections at a public hospital: do public housing and incarceration amplify transmission? Arch Intern Med (2007) 2.07
Optimum lymphadenectomy for esophageal cancer. Ann Surg (2010) 2.01
Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrob Agents Chemother (2006) 1.94
Lung cancer screening: is it time for a change in policy? Cleve Clin J Med (2007) 1.93
The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol. Clin Gastroenterol Hepatol (2008) 1.85
A phase I study with neratinib (HKI-272), an irreversible pan ErbB receptor tyrosine kinase inhibitor, in patients with solid tumors. Clin Cancer Res (2009) 1.79
F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma. J Clin Oncol (2003) 1.70
A critical evaluation of a percutaneous diagnostic and treatment strategy for chylothorax after thoracic surgery. Eur J Cardiothorac Surg (2008) 1.69
Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapy. J Urol (2007) 1.66
p53 expression in low grade dysplasia in Barrett's esophagus: correlation with interobserver agreement and disease progression. Am J Gastroenterol (2002) 1.58
Role of clinically determined depth of tumor invasion in the treatment of esophageal carcinoma. J Thorac Cardiovasc Surg (2003) 1.57
Chest computerized tomography in the evaluation of uveitis in elderly women. Am J Ophthalmol (2002) 1.55
Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array. Thorax (2007) 1.54
Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out. Cancer Res (2009) 1.53
Induction chemoradiotherapy increases pleural and pericardial complications after esophagectomy for cancer. J Thorac Oncol (2009) 1.47
Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies. Am J Gastroenterol (2008) 1.46
Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes. Ann Surg (2008) 1.46
An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients. Gastrointest Endosc (2009) 1.44
Endoscopic clips for closing esophageal perforations: case report and pooled analysis. Gastrointest Endosc (2007) 1.43
Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma. J Thorac Cardiovasc Surg (2003) 1.41
T2N0M0 esophageal cancer. J Thorac Cardiovasc Surg (2007) 1.38
European guidelines on structure and qualification of general thoracic surgery. Eur J Cardiothorac Surg (2014) 1.35
Impact of ring wearing on hand contamination and comparison of hand hygiene agents in a hospital. Clin Infect Dis (2003) 1.34
Stereotactic radiosurgery for lung tumors: preliminary report of a phase I trial. Ann Thorac Surg (2003) 1.34
Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial. J Clin Oncol (2005) 1.34
The pathogenesis of pseudoachalasia: a clinicopathologic study of 13 cases of a rare entity. Am J Surg Pathol (2002) 1.29
A phase I dose-escalation study of Tivantinib (ARQ 197) in adult patients with metastatic solid tumors. Clin Cancer Res (2011) 1.27
Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations. J Clin Endocrinol Metab (2011) 1.25
Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model. Eur J Hum Genet (2011) 1.25
Impact of smoking cessation before resection of lung cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database study. Ann Thorac Surg (2009) 1.25
Atrial fibrillation complicating lung cancer resection. J Thorac Cardiovasc Surg (2005) 1.25
Risk factors for hypopharyngeal/upper esophageal stricture formation after concurrent chemoradiation. Head Neck (2006) 1.23
Possible overestimation of penicillin resistant Streptococcus pneumoniae colonization rates due to misidentification of oropharyngeal streptococci. Diagn Microbiol Infect Dis (2002) 1.22
A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: the Cleveland Clinic experience. J Thorac Oncol (2009) 1.22
Adenocarcinoma of the small bowel: a study of 37 cases with emphasis on histologic prognostic factors. Dis Colon Rectum (2002) 1.22
Symptom evaluation in palliative medicine: patient report vs systematic assessment. Support Care Cancer (2006) 1.21
A phase I study of sunitinib plus bevacizumab in advanced solid tumors. Clin Cancer Res (2009) 1.19
Characterization and importance of air leak after lobectomy. Ann Thorac Surg (2005) 1.19
Exhaled breath analysis with a colorimetric sensor array for the identification and characterization of lung cancer. J Thorac Oncol (2012) 1.19
Endoscopic ultrasound errors in esophageal cancer. Am J Gastroenterol (2005) 1.17
Lymph node ratio: a confounded quotient. Ann Thorac Surg (2013) 1.15
Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10. Hum Mutat (2011) 1.12
Can we predict long-term survival after pulmonary metastasectomy for renal cell carcinoma? Ann Thorac Surg (2005) 1.11
Mediastinal synovial sarcoma: report of two cases with molecular genetic analysis. Ann Thorac Surg (2002) 1.11
Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? Head Neck (2003) 1.09
S100beta as a predictor of brain metastases: brain versus cerebrovascular damage. Cancer (2005) 1.09
Prognostic roles of human equilibrative transporter 1 (hENT-1) and ribonucleoside reductase subunit M1 (RRM1) in resected pancreatic cancer. Cancer (2011) 1.08
Complexities of managing achalasia at a tertiary referral center: use of pneumatic dilatation, Heller myotomy, and botulinum toxin injection. Am J Gastroenterol (2004) 1.08
Prognostic importance of resection margin width after nephron-sparing surgery for renal cell carcinoma. Urology (2002) 1.07
The seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Staging Manuals: the new era of data-driven revisions. J Thorac Cardiovasc Surg (2010) 1.07
Enteral feeding tubes in patients undergoing definitive chemoradiation therapy for head-and-neck cancer: a critical review. Int J Radiat Oncol Biol Phys (2012) 1.06
Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junction. J Thorac Oncol (2009) 1.05
Malignant pleural effusion: one size does not fit all. Ann Thorac Surg (2013) 1.05
Brain metastases from esophageal cancer: a phenomenon of adjuvant therapy? Ann Thorac Surg (2006) 1.04
Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer With hyperfractionated radiation and concurrent chemotherapy. J Clin Oncol (2002) 1.03
Does esophagogastric anastomotic technique influence the outcome of patients with esophageal cancer? J Thorac Cardiovasc Surg (2005) 1.02
Comparison of routine glove use and contact-isolation precautions to prevent transmission of multidrug-resistant bacteria in a long-term care facility. J Am Geriatr Soc (2004) 1.01
Chromosomal gains and genomic loss of p53 and p16 genes in Barrett's esophagus detected by fluorescence in situ hybridization of cytology specimens. Mod Pathol (2004) 1.00
Does core needle breast biopsy accurately reflect breast pathology? Surgery (2003) 0.99
Recursive partitioning analysis index is predictive for overall survival in patients undergoing spine stereotactic body radiation therapy for spinal metastases. Int J Radiat Oncol Biol Phys (2011) 0.99
Epidemiological approach to identifying genetic predispositions for atypical hemolytic uremic syndrome. Ann Hum Genet (2010) 0.97
Sunitinib-induced macrocytosis in patients with metastatic renal cell carcinoma. Cancer (2008) 0.97
Referent values and equipoise: editors' notes. J Thorac Cardiovasc Surg (2009) 0.97
Is FDG-PET indicated for superficial esophageal cancer? Eur J Cardiothorac Surg (2007) 0.96
Diagnosis and staging of cancer of the esophagus and esophagogastric junction. Surg Clin North Am (2012) 0.96
Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810). Lung Cancer (2007) 0.96
An Official American Thoracic Society/American College of Chest Physicians Policy Statement: Implementation of Low-Dose Computed Tomography Lung Cancer Screening Programs in Clinical Practice. Am J Respir Crit Care Med (2015) 0.96